Kuangli Bio-Tech Holdings Co., Ltd. (TPE:6431)

Kuangli Bio-Tech Holdings Revenue

Kuangli Bio-Tech Holdings had revenue of 85.85M TWD in the quarter ending March 31, 2026, a decrease of -21.73%. This brings the company's revenue in the last twelve months to 353.20M, down -17.62% year-over-year. In the year 2025, Kuangli Bio-Tech Holdings had annual revenue of 377.03M, down -1.12%.

• Revenue (ttm): 353.20M
• Revenue Growth: -17.62%
• P/S Ratio: 5.14
• Revenue / Employee: n/a
• Employees: 180
• Market Cap: 1.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	377.03M	-4.27M	-1.12%
Dec 31, 2024	381.30M	87.93M	29.97%
Dec 31, 2023	293.37M	-48.79M	-14.26%
Dec 31, 2022	342.16M	9.53M	2.86%
Dec 31, 2021	332.63M	245.66M	282.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error